Andres McAllister
Technik-/Wissenschafts-/F&E-Leiter bei BIOINVENT INTERNATIONAL AB
Vermögen: 7 128 $ am 30.04.2024
Aktive Positionen von Andres McAllister
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOINVENT INTERNATIONAL AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | - |
Karriereverlauf von Andres McAllister
Ehemalige bekannte Positionen von Andres McAllister
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2004 | 01.09.2015 |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia. | Direktor/Vorstandsmitglied | - | - |
Centre d'Immunologie Pierre Fabre | Corporate Officer/Principal | - | - |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Corporate Officer/Principal | - | - |
The University of California, San Francisco | Corporate Officer/Principal | - | - |
IMMUNE DESIGN CORP | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Andres McAllister
Universidad del Rosario | Doctorate Degree |
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Statistik
International
Frankreich | 4 |
Vereinigte Staaten | 3 |
Schweiz | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOINVENT INTERNATIONAL AB | Health Technology |
Private Unternehmen | 5 |
---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Miscellaneous |
Centre d'Immunologie Pierre Fabre | |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Immunexpress Pty Ltd. engages in creating molecular diagnostics for sepsis. The company was founded by Roslyn Brandon, Mervyn Rees Thomas and Richard Bruce Brandon and in 2006 and is headquartered in Toowong, Australia. | Health Technology |
- Börse
- Insiders
- Andres McAllister
- Erfahrung